Citrus-derived gastrointestinal comfort blends sales will expand through 2036, with pectin-fiber blends holding 29.0% of the ingredient type segment in 2026. The market was valued at USD 300.9 million in 2025 and is projected to grow from USD 322.8 million in 2026 to USD 651.0 million by 2036.